Literature DB >> 33347563

Natural History of Thyroid Disease in Children with PTEN Hamartoma Tumor Syndrome.

Jessica R Smith1, Enju Liu2, Alanna J Church3, Elizabeth Asch4, Christine E Cherella1, Siddharth Srivastava5, Junne Kamihara6, Ari J Wassner1.   

Abstract

CONTEXT: Thyroid ultrasound screening is recommended in children with PTEN hamartoma tumor syndrome (PHTS) due to increased risk of thyroid neoplasia, but the natural history of thyroid disease in children with PHTS is unclear.
OBJECTIVE: Determine the prevalence and natural history of thyroid disease in children with PHTS.
METHODS: Retrospective cohort study (1998-2019) in an academic pediatric hospital of individuals with genetically confirmed PHTS diagnosed before age 19 years. Clinical, thyroid ultrasound, and laboratory characteristics are described. Primary outcomes were the prevalence of thyroid nodules ≥10 mm diameter and time course and risk factors for nodule development assessed by Cox regression analysis. Secondary outcomes included thyroid nodule requiring biopsy, other ultrasound findings, and prevalence of autoimmune thyroid disease.
RESULTS: Among 64 subjects with PHTS, 50 underwent thyroid ultrasound. A thyroid nodule ≥10 mm was diagnosed in 22/50 (44%) subjects at median (range) age 13.3 (7.0-22.9) years. Nodules were diagnosed earlier in females than in males (10.8 [7.0-17.9] vs 14.2 [9.9-22.9] years, P = .009). In multivariate analysis, risk of thyroid nodules was significantly associated with female sex (hazard ratio 2.90, 95% CI 1.16-7.27, P = .02) and inversely associated with the presence of neurologic findings of PHTS (HR 0.27, 95% CI 0.10-0.69, P = .007). Abnormal-appearing lymph nodes with echogenic foci were observed by ultrasound in 20% of subjects, but these were not associated with malignancy. Autoimmune thyroid disease was present in 10/33 (30.3%) of subjects in whom it was assessed.
CONCLUSION: Thyroid disease is common in children with PHTS. This study supports current consensus recommendations for ultrasound screening.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  PTEN; hamartoma; pediatric; screening; thyroid; ultrasound

Year:  2021        PMID: 33347563     DOI: 10.1210/clinem/dgaa944

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  3 in total

1.  The Clinical Spectrum of PTEN Hamartoma Tumor Syndrome: Exploring the Value of Thyroid Surveillance.

Authors:  Julia A Baran; Steven D Tsai; Amber Isaza; Garrett M Brodeur; Suzanne P MacFarland; Kristin Zelley; Denise M Adams; Aime T Franco; Andrew J Bauer
Journal:  Horm Res Paediatr       Date:  2021-04-22       Impact factor: 2.852

Review 2.  PTEN hamartoma tumor syndrome in childhood and adolescence-a comprehensive review and presentation of the German pediatric guideline.

Authors:  Michaela Plamper; Bettina Gohlke; Joachim Woelfle
Journal:  Mol Cell Pediatr       Date:  2022-02-21

3.  "Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)".

Authors:  Gerdi Tuli; Jessica Munarin; Alessandro Mussa; Diana Carli; Roberto Gastaldi; Paola Borgia; Maria Cristina Vigone; Marco Abbate; Giovanni Battista Ferrero; Luisa De Sanctis
Journal:  Endocrine       Date:  2021-06-28       Impact factor: 3.633

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.